# OnCo record nct07391657 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07391657/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07391657", "NCT07391657" ;
  schema:name "A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Rela"@en ;
  schema:alternateName "DURGA-4"@en ;
  schema:description "A phase 3 trial of Daratumumab, Carfilzomib, Dexamethasone in multiple myeloma, run by AstraZeneca, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07391657/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07391657> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2026-02-23" ;
  onco:cancers <https://onco.cc/cancers/multiple-myeloma/>, <https://onco.cc/cancers/myeloma-relapsed-refractory/> ;
  onco:drugs <https://onco.cc/drugs/daratumumab/>, <https://onco.cc/drugs/carfilzomib/>, <https://onco.cc/drugs/dexamethasone/>, <https://onco.cc/drugs/bortezomib/>, <https://onco.cc/drugs/pomalidomide/> ;
  onco:companies <https://onco.cc/companies/astrazeneca/> .